Activated Partial Thromboplastin Time measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
44
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Mixed Cellularity Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
19
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Neonatal Systemic lupus erythematosus
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
22
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Generalized vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
43
|
16
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Polymyalgia Rheumatica
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
51
|
7
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Azoospermia, Nonobstructive
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
91
|
22
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Alopecia Areata
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
114
|
54
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Small Lymphocytic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
120
|
122
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
132
|
36
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
3
|
2009 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
3
|
2009 |
2010 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
2 |
3
|
2009 |
2010 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
2 |
3
|
2009 |
2010 |
Child Development Disorders, Pervasive
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
168
|
379
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Non-obstructive azoospermia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
168
|
88
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Membranous glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
197
|
33
|
0.100 |
None |
1.000 |
1 |
2
|
2011 |
2011 |
Allergic Reaction
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
197
|
1019
|
0.100 |
None |
1.000 |
1 |
15
|
2013 |
2013 |
Pick Disease of the Brain
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
213
|
83
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Giant Cell Arteritis
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
260
|
78
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
302
|
92
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Narcolepsy
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
308
|
454
|
0.100 |
None |
1.000 |
2 |
11
|
2009 |
2010 |
Frontotemporal dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
320
|
215
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Myasthenia Gravis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
336
|
93
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Lymphocyte Count measurement
|
phenotype |
|
Laboratory Procedure
|
338
|
456
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2016 |